RxDoctor Payments Data

Mathew Romankowski, MD

Pain Medicine · Salt Lake City, UTNPI 1538505409

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,789 of the $2,033 with a category attached, or 88.0%. It is spread thinly across 10 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $676 and has fallen 83.7% since, to $110 in 2024. That places this record below the midpoint for pain medicine clinicians in UT, where the typical reported total is $3,451.

$2,033in general payments, 2019–2025

Across 42 payments — averaging $48.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$434
  • Abbott$428
  • Organogenesis Inc.$329
  • Relievant Medsystems, Inc.$289
  • SPR Therapeutics, Inc$266
  • Stimwave Technologies Incorporated$129
  • plus $159 from 4 others

What the payments were for

  • Travel & lodging$24312%
  • Food & beverage$1,78988%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)13$434
Abbott6$428
Organogenesis Inc.4$329
Relievant Medsystems, Inc.8$289
SPR Therapeutics, Inc4$266
Stimwave Technologies Incorporated2$129
Stratus Medical, LLC2$75
Boston Scientific1$47
AbbVie1$21
Stryker1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,033 in reported general payments places this provider in the 40th percentile of 61 pain medicine providers in Utah.

See all pain medicine providers in Utah

Medicare billing

Part B allowed, 2024
$137,283
Medicare patients
139
Services billed
3,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin85$2,355
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$1,205
Meloxicam34$586
Celecoxib24$396
Duloxetine Hcl11$268
Diclofenac Sodium19$255
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$246
Pregabalin12$206
Ibuprofen11$114

Paid to pharmacies, not to this prescriber.

Other pain medicine in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →